Skip to main content

Tackling Sickness Absence in the NHS: The Importance of Staff Well-being on Healthcare Delivery

The National Health Service (NHS) in England requires the ability to maintain adequate staffing levels across all professional groups. A crucial aspect of this challenge is managing sickness absence rates among NHS staff, which not only impacts patient care and operational costs but also plays a pivotal role in workforce retention and overall healthcare efficacy. Our recent paper in the Journal of the Royal Society of Medicine discusses this important challenge for the NHS.

Recent data published by NHS Digital indicates a worrying trend: sickness absence rates have been on a steady rise across all NHS staff groups since 2009, with a notable surge during the COVID-19 pandemic. This trend has resulted in absence rates remaining elevated above pre-pandemic levels, signaling a potential crisis in staffing and healthcare delivery.

The Dynamics of Sickness Absence Rates

Before the pandemic, monthly sickness absence rates typically varied between 4% and 5%, with expected seasonal variations. However, the pandemic era saw these rates spike to around 6%, and even after the lifting of most COVID-19 restrictions, they have hovered between 5% and 6%. In comparison, the general UK workforce has exhibited more stable sickness absence rates, with NHS employees displaying approximately double the absence rates of their counterparts in other sectors. This disparity underscores the unique pressures faced by NHS staff, including high-stress environments and demanding physical work conditions.

Mental Health at the Forefront

A significant finding from the NHS England data is the high prevalence of mental ill health, particularly anxiety and depression, as a leading cause of sickness absence among NHS staff. This contrasts with the broader employment landscape, where other illnesses predominate. The data suggests that NHS staff are substantially more likely to take leave for mental health reasons, a situation likely exacerbated by the demanding conditions of NHS work environments.

Variations and Implications for Policy

Sickness absence rates vary across different professional groups within the NHS, with doctors generally showing lower rates than other groups such as nursing, ambulance, and allied health professionals. This variance highlights the need for a nuanced approach to addressing sickness absence, considering factors such as role flexibility, work conditions, and the potential for presenteeism.

Addressing these issues requires more than reactive measures; it demands a proactive strategy that includes improving access to occupational health services, mental health resources, and implementing systemic changes to address the root causes of high sickness absence rates. The NHS workforce plan looks to the national Growing Occupational Health and Wellbeing Strategy for solutions, but there is a clear need for more comprehensive, data-driven approaches that tackle the underlying factors contributing to workforce strain.

Conclusions

Ultimately, understanding and mitigating the reasons behind elevated sickness absence rates - particularly those related to mental health and varying across professional groups - will be crucial for closing the gap between the NHS and the broader UK workforce. This effort will not only enhance workforce well-being but also ensure the sustainability of high-quality healthcare delivery within the NHS.

Comments

Popular posts from this blog

MPH Student Presentations on the NHS Care.Data Programme

As part of a session on primary care data in the Health Informatics module on the Imperial Master of Public Health Programme, I asked students to work in two groups to present arguments for and against the NHS Care.Data programme. Care.Data is an NHS programme that will extract data from the medical records held by general practitioners (GPs) in England. The Care.Data programme takes advantage of the very high level of use of electronic medical records by GPs in England. After extraction, data will be uploaded to the NHS Health and Social Care Information Centre (HSCIC). The data will then be used for functions such as health care planning, monitoring disease patterns and research. The programme has been controversial with proponents arguing that the programme will bring many benefits for the NHS and the population of England; and opponents arguing it is a major breach of privacy. You can view the two presentations to help inform you further about these arguments: Arguments fo...

The Hidden Cost of Cheaper NHS Contracts: Losing Community Trust

NHS budgets are under considerable pressure. It is therefore unsurprising that many NHS Integrated Care Boards (ICBs) In England will aim to prioritise price in contract awards, But this approach is a significant threat to community-centred healthcare. While competitive tendering is a legally required, an excessive focus on costs in awarding NHS contracts risks overshadowing key factors such as established community trust, local expertise, and the long-term impact on continuity of care. This shift towards cheaper, often external, commercial providers threatens to cut the links between communities and their local health services. The argument that competitive tendering is solely about legal compliance, and not cost, is undermined by the very nature of such tendering, which by design encourages the lowest bid. This approach risks eroding the social fabric of local healthcare provision, where established relationships and understanding of specific community needs are essential. Establishe...

Talking to Patients About Weight-Loss Drugs

The use of weight-loss drugs such as GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) has increased rapidly in recent years. These drugs can help some people achieve significant weight reduction, but they are not suitable for everyone and require careful counselling before starting treatment. By discussing benefits, risks, practicalities, and  uncertainties, clinicians can help patients make informed, realistic decisions about their treatment. Key points to discuss with patients 1. Indications and eligibility These drugs are usually licensed for adults with a specific BMI. They should be used alongside lifestyle interventions such as dietary change, increased physical activity, and behaviour modification. 2. Potential side effects – some can be serious Common adverse effects include nausea, vomiting, diarrhoea, and abdominal discomfort. Less common but more serious risks include gallstones, pancreatitis and visual problems. Patients should know what to watch for a...